X-twitter Linkedin Youtube

A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env

Clinical Therapeutics, July 13, 2019

https://www.clinicaltherapeutics.com/article/S0149-2918(19)30296-6/pdf

Tagged

© 2024 GeNeuro SA

 3, Chemin du Pré-Fleuri
CH-1228 Plan-les-Ouates
Geneva, Switzerland

X-twitter Linkedin Youtube